Home LiteratureArticle Details
PMID: 15383520 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history.

JAMA ·Vol. 292 ·No. 12 ·2004-09-22 ·Pages 1480-9

Murff HJ, Spigel DR, Syngal S

Abstract

A family history of certain cancers is associated with an increased risk of developing cancer. Both cancer screening and genetic services referral decisions are often based on self-reported pedigree information. To determine the accuracy of self-reported family cancer history information. English-language articles were retrieved by searching MEDLINE (1966-June 2004) using Medical Subject Headings family, genetic predisposition to disease, medical history taking, neoplasm, and reproducibility of results. Additional articles were identified through bibliography searches. Original studies in which investigators validated self-reported family history by reviewing the identified relatives' medical records, death certificate, or cancer registry information were included, as well as studies that evaluated breast, colon, ovarian, endometrial, and prostate cancers. Two of the 3 investigators independently reviewed and abstracted data for estimating the likelihood ratios (LRs) of self-reported family cancer history information. Only data from studies that evaluated both positive and negative family cancer histories were included within the analyses. A total of 14 studies met the search criteria and were included in the review. For patients without a personal history of cancer, the positive and negative LRs of a family history of the following cancers in a first-degree relative were 23.0 (95% confidence interval [CI], 6.4-81.0) and 0.25 (95% CI, 0.10-0.63) for colon cancer; 8.9 (95% CI, 5.4-15.0) and 0.20 (95% CI, 0.08-0.49) for breast cancer; 14.0 (95% CI, 2.2-83.4) and 0.68 (95% CI, 0.31-1.52) for endometrial cancer; 34.0 (95% CI, 5.7-202.0) and 0.51 (95% CI, 0.13-2.10) for ovarian cancer; and 12.3 (95% CI, 6.5-24.0) and 0.32 (95% CI, 0.18-0.55) for prostate cancer, respectively. Positive predictive values tended to be better in articles concerning first-degree relatives compared with second-degree relatives. Patient-reported family cancer histories for first-degree relatives are accurate and valuable for breast and colon cancer risk assessments. Negative family history reports for ovarian and endometrial cancers are less useful, although the prevalence of these malignancies within families is low.

MeSH Terms
Family Genetic Predisposition to Disease Genetic Testing Humans Medical History Taking Neoplasms/genetics Pedigree Risk Factors Sensitivity and Specificity
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Murff Harvey J
Division of General Internal Medicine, Vanderbilt University Medical Center, and Department of Veterans Affairs, Tennessee Valley Healthcare System, Research Education and Clinical Center, Nashville, Tenn 37212-2637, USA. harvey.murff@med.va.gov
Spigel David R
Syngal Sapna
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
1538-3598
Published
2004-09-22
Pages
1480-9
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Grants
NCI NIH HHS · K07CA08453 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com